Difficult Decisions in the Care of Patients with Hematologic Malignancies

March 25, 2022

IMPORTANT BROWSER INFORMATION

This site will not work on Internet Explorer 8. Please use:

Google Chrome      Mozilla FIREFOX   Safari     Oper

 

Sidney Kimmel Cancer Network Annual Meeting


The Jefferson Oncology Group “Difficult Decisions in the Care of Patients with Hematologic Malignancies” offers participants the opportunity to observe experts debate and deliberate how they would manage treatment of patients with hematologic malignancies and myelodysplastic syndromes.  This active learning format will feature lectures on the current role of CAR-T cells among chemotherapies and immunotherapies presently available to patients. The meeting will review emerging novel therapies, therapeutic developments, and latest clinical research findings from “bench to bedside” for improving patient outcomes. Panel discussions will provide participants the opportunity to examine cases from multiple perspectives and gain knowledge of how experienced clinicians approach difficult patient care decisions for the hematologic cancer patients they treat.

SUCCESSFUL COMPLETION

To successfully complete this activity, the required evaluation must be completed no later than Monday, May 9, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Target Audience

The target audience for this educational activity includes Sidney Kimmel Cancer Center faculty, staff, residents, and fellows and Sidney Kimmel Cancer Network physicians, nurses, PAs, and other healthcare professionals.

Learning Objectives

Following the completion of this educational activity, learners will be able to:

  1. Identify current applications of chimeric antigen receptor therapy (CAR-T).
  2. Evaluate emerging clinical data and novel therapies for patients with hematologic malignancies.
  3. Describe current approaches in hematopoietic stem cell transplantation (HSCT).
Additional information
Jefferson Content Development By: 
Sidney Kimmel Cancer Center (SKCC)
Sidney Kimmel Cancer Center (SKCC) CONSORTIUM PARTNER
Sidney Kimmel Cancer Center (SKCCN) NETWORK MEMBER
Content Areas: 
Hematology
Oncology
Course Format: 
Live Webinar
Course summary
Available credit: 
  • 2.75 AMA PRA Category 1 Credit
  • 2.75 Attendance
  • 2.58 CNE
  • 2.00 CNE Pharmacotherapy
  • 2.00 Patient Safety
Course opens: 
01/03/2022
Course expires: 
05/09/2022
Event starts: 
03/25/2022 - 2:00pm EDT
Event ends: 
03/25/2022 - 4:30pm EDT
Cost:
$25.00

COMMERCIAL/IN-KIND SUPPORT

Any support received for this educational activity will be published and announced prior to the start of the activity.

Agenda

Agenda subject to change.


 

imagePROGRAM ACCESS

This is a live virtual program.

  1. Participants who register for the program will be sent a zoom login email.
  2. Participants must 'register' through zoom to access the program (via the zoom platform). Use the same name as submitted when registering to help in identifying participation.
  3. The zoom link will be active 1 hour before the start of the program.
  4. Please click here to send an email if you encounter any problems accessing the program.

Financial Relationships

Thomas Jefferson University endorses the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined ineligible entities within the past 24 months. Any conflict of interests have been mitigated prior to this educational activity.

Such disclosures will be available prior to the start of the activity. ​OCPD Conflict of Interest resolution process may result in changes to the program agenda.

PLANNING COMMITTEE

The following planning committee members have no financial relationships to disclose:
Rita Axelrod, MD-Activity Director
Lindsay Wilde, MD
Barbara Fischer, BSN, RN, OCN
Anett Petrich, MSN, RN
Kathleen O’Doherty, BSN, RN, OCN

The following planning committee member has financial relationships to disclose:
Usama Gergis, MD, MBA
  Disclosure: Advisor/Speaker: Astellas, Incyte, Jazz Pharmaceuticals, Kite; Advisor: Gamida
                         Stock/Stock Options: Biontech, Gamida, Iovance, Moderna, Omeros
Christine Bonaccorso, DNP, RN, OCN
  Disclosure: Stock/Stock Options: Adaptimmune and Nabriva

Faculty

The following faculty have financial relationships to disclose:
Ubaldo Martinez-Outschoorn MD
  Researcher: Otsuka Pharmaceuticals
Usama Gergis, MD, MBA
  Advisor/Speaker: Astellas, Incyte, Jazz Pharmaceuticals, Kite; Advisor: Gamida
                         Stock/Stock Options: Biontech, Gamida, Iovance, Moderna, Omeros
Pierluigi Porcu, MD
  Consultant: Daiichi, Dren Bio, Innate Pharma, Kyowa, Secura Bio, Viracta

The following faculty have no financial relationships to disclose:
Rita Axelrod, MD
Lindsay Wilde, MD
Neil Palmisiano, MD, MS
Gina Keiffer, MD
Andres Ferber, MD
Gabor Varadi, MD
Aarti Shevade, MD
Michael Millenson, MD

Off‐label/Investigational Use

All presenters are required to disclose whether their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

 

https://jointaccreditation.org/sites/default/files/JointlyAccreditedProviderTM_0.pngIn support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

CREDIT DESIGNATION

Physicians: This educational activity is designated for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 2.58 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 2.75 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

Nursing Pharmacology Credits

All three case presentations in this educational activity qualify for nursing pharmacology credits.
Credits: 2.0

PA Patient Safety and Risk Credits

All three case presentations in this educational activity qualify for PA Patient Safety and Risk credits.
Credits: 2.0

 

Available Credit

  • 2.75 AMA PRA Category 1 Credit
  • 2.75 Attendance
  • 2.58 CNE
  • 2.00 CNE Pharmacotherapy
  • 2.00 Patient Safety

Virtual exhibit opportunities are available for this conference. For more information, please contact Carol Goddard.

Price

Cost:
$25.00
Please login or register to take this course.

Registration Fees

Profession/AffiliationFee
Sidney Kimmel Cancer Center Faculty, Staff, Residents, and Fellows
(Center City, Methodist, Jefferson Abington-Asplundh Cancer Pavilion, Jefferson Einstein, Jefferson Northeast, Jefferson New Jersey)
Complimentary
Sidney Kimmel Cancer Network MemberComplimentary
Main Line Health Oncology Providers and Staff                                    Complimentary
Other Practicing Physician/Nurse/Health Professional$25

Zoom Access

Instructions on accessing the zoom meeting will be emailed to registrants one day before the activity date. The zoom link will be active one hour before start time.

REGISTRATION INFORMATION

To register online, you must have a CPD @ JeffLearn account.

  1. Login or create an account. - Note: This website will not work on Internet Explorer 8. 
  2. Final price will be reflected on check out. You must be logged in to see the "Add to Cart" function.  
  3. Check out and pay with American Express, Visa or Mastercard. 

Refunds

No refunds will be given after Friday, March 11, 2022. See full refund policy

Requests for refunds must be submitted in writing and received by OCPD before Friday, March 11, 2022. Registrants who fail to attend the conference are responsible for the entire registration fee. All refunds will be processed after the conference concludes.

Should any emergency arise, of any nature, prior to the opening conference date that would prevent its schedule opening (destruction or damage to the facility by fire, flood, storms, acts of God, etc., or declaration of any emergency by the state of Pennsylvania or the United States Government), Jefferson reserves the right to cancel or postpone the conference. In the event of cancellation or postponement, Jefferson will refund registration fees, but is not responsible for related costs or expenses to registrants, including cancellation fees assessed by hotels, airlines or travel agencies.

RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED

Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.

JEFFERSON RELEASE POLICY

Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt and distribute at any time in any manner or medium.

You understand that it is your right to withhold consent to this Jefferson policy or to withdraw your previous consent at any time. You further understand that, without your consent, it is not possible to process your course registration request.

JEFFERSON HIPAA POLICY

You understand that, as an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).

You agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You agree that you will take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity.

In furtherance of the above, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information by the undersigned may result in possible legal action against you by Jefferson whose confidentiality is breached.